Jan Adolfsson

Karolinska Institutet — Sweden

Medicine · Health Sciences

63h-index15.3kcitations350works81.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(169), Prostate Cancer Diagnosis and Treatment(145), Bladder and Urothelial Cancer Treatments(45), Global Cancer Incidence and Screening(28), Hormonal and reproductive studies(23)

Publications345 total

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
JAMA·2024· 81 citedOpen Access
A systematic review of hormone treatment for children with gender dysphoria and recommendations for research
Acta Paediatrica·2023· 82 citedOpen Access
Magnetic resonance imaging of the knee for chronological age estimation—a systematic review
European Radiology·2023· 11 citedOpen Access
PD38-11 THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP
The Journal of Urology·2023
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden
Journal of Oncology·2023· 2 citedOpen Access
The Stockholm3 prostate cancer screening trial (STHLM3): An interim analysis of mortality results after 6.5 years of follow-up
European Urology·2023· 2 cited
Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
British Journal of Cancer·2022· 4 citedOpen Access
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
European Urology Open Science·2022· 2 citedOpen Access
Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
JAMA Network Open·2022· 8 citedOpen Access
Citing and endpoints
Scandinavian Journal of Urology·2022Open Access
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
Scandinavian Journal of Urology·2022· 4 citedOpen Access
The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development
Journal of Clinical Epidemiology·2022· 12 citedOpen Access
Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network–McMaster Guideline Development Checklist
Annals of Internal Medicine·2022· 13 citedOpen Access
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
Figshare·2022Open Access
Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
BMC Cancer·2021· 2 citedOpen Access
Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort
BJUI Compass·2021· 41 citedOpen Access
Exploring the Association Between Prostate Cancer Diagnosis per se and use of GnRH Agonists and Diabetes Control in Men with type 2 Diabetes Mellitus: A Nationwide, Population-Based Cohort Study
Research Square (Research Square)·2021Open Access
Diabetes control in men with type 2 diabetes mellitus and prostate cancer treated with GnRH Agonists: A nationwide, population-based cohort study
European Urology·2021· 1 cited
Guideline-based quality assurance: a conceptual framework for the definition of key elements
BMC Health Services Research·2021· 21 citedOpen Access
Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes
BMC Health Services Research·2021· 16 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Gunnar Steineck(12), Henrik Grönberg(10), Pär Stattin(8), Lars Holmberg(7), Fredrik Wiklund(7), Markus Aly(7), Hans Garmo(7), Mieke Van Hemelrijck(7), Mats Lambe(6), Anna Bill‐Axelson(6), Jianfeng Xu(6), Paul W. Dickman(5), Peter Wiklund(5), William B. Isaacs(5), Ásgeir R. Helgason(5), Mark Clements(4), Hans‐Olov Adami(4), Ola Bratt(4), Stefan Arver(4), Jan‐Erik Johansson(3)